Stocktoria
CollPlant Biotechnologies Ltd CLGN
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 1993-09-01
CollPlant Biotechnologies Ltd financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.4M | $515,000 | $11.0M | $299,000 | $15.6M |
| Gross profit | $1.5M | -$1.1M | $9.0M | -$101,000 | $13.6M |
| R&D expense | $8.2M | $10.5M | $10.5M | $10.3M | $7.6M |
| Operating income | -$11.5M | -$17.3M | -$7.5M | -$17.1M | $65,000 |
| Income tax | — | $46.0M | $60.0M | — | — |
| Net income | -$11.5M | -$16.6M | -$7.0M | -$16.9M | $237,000 |
| EPS (diluted) | $-0.94 | $-1.45 | $-0.62 | $-1.53 | $0.02 |
| Operating cash flow | -$9.4M | -$14.1M | -$2.8M | -$13.7M | $2.5M |
| Free cash flow | -$9.4M | -$14.6M | -$3.7M | -$15.0M | $1.1M |
| Cash & equivalents | $5.6M | $11.9M | $26.7M | $29.7M | $13.1M |
| Inventory | $573,000 | $440,000 | $714,000 | $1.4M | $1.1M |
| Total assets | $10.8M | $18.7M | $34.1M | $37.8M | $51.2M |
| Total liabilities | $4.7M | $5.2M | $5.8M | $5.5M | $6.1M |
| Shareholders' equity | $6.1M | $13.5M | $28.3M | $32.3M | $45.1M |
Source: SEC EDGAR filings · CIK 0001631487 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.